Bibliography
- Van Zuuren EJ, Graber MA, Hollis S, et al. Interventions for rosacea (Cochrane Review). The Cochrane Library 2003; Issue 4. Chichester, UK: John Wiley & Sons. Available from: www.thecochranelibrary.com [Last accessed 11 October 2007]
- Berth Jones J. Rosacea, perioral dermatitis and similar dermatoses, flushing and flushing syndromes. In: Burns T, Breathnach S, Cox N & Griffiths C, editors, Rook's textbook of dermatology. 7th edition. Oxford: Blackwell; 2004. p. 44.1-44.19
- PRODIGY quick reference guide, February 2006. Available from: http://cks.library.nhs.uk/rosacea/ quick_reference_guide [Last accessed 12 October 2007]
- Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002;46:584-7
- Blount BW. Rosacea a common yet commonly overlooked condition. Am Fam Physician 2002;66:435-40
- Barco D, Alomar A. Rosacea. Actas Dermosifiliogr 2008;99:244-56
- Del Rosso JQ. A status report on medical management of rosacea: focus on topical therapies. Cutis 2002;70:271-5
- Lomholt G. Prevalence of skin diseases in a population – a consensus study from the Faroe Islands. Dan Med Bull 1964;11:1-7
- Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol (Stockh) 1989;69:419-23
- Crawford GH, Pelle MT, James WD. Rosacea. Etiology, pathogenesis and subtype classification. J Am Acad Dermatol 2004;51:327-41
- Rebora A. The red face: rosacea. Clin Dermatol 1993;11:225-34
- Powell FC. Rosacea. N Engl J Med 2005;352:793-803
- Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg 2001;20:199-206
- Balkrishnan R. Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol 2006;4592:111-5
- Fleischer A, Chen S. The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. J Drugs Dermatol 2005;4:585-90
- Elewski BE. Azelaic acid 15% for treatment of rosacea. Expert Rev Dermatol 2006;1:535-45
- Rebora A. The management of rosacea. Am J Clin Dermatol 2002;3:489-96
- Van Zuuren EJ, Gupta AK, Gover MD, et al. Systematic review of rosacea treatments. J Am Acad Dermatol 2007;56:107-15
- Liu R, Smith M, Basta S, Farmer E. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomised controlled trials. Arch Dermatol 2006;142:1047-52
- Stone D, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Cur Opin Ophthalmol 2004;15:499-502
- Yoo J, Reid DC, Kimball AB. Metronidazole in the treatment of rosacea: do formulation, dosing and concentration matter? J Drugs Dermatol 2006;5:317-9
- Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 2007;56:791-802
- Van Landuyt H, Joubert Lequain I, Humbert P, et al. Treatment of rosacea. Clonidine (0.75 mg per day) versus placebo (initial results). Ann Dermatol Venereol 1997;124:729
- Grosshans E, Michel C, Arcade B, Cribier B. Rilmenidine in rosacea: a double-blind study versus placebo. Ann Dermatol Venereol 1997;124:687-91
- Wilkin JK. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 1989;20:202-5
- Available from: http://clinicaltrials.gov
- Bikowski JB, Goldman MP. Rosacea; where are we now? J Drugs Dermatol 2004;3:251-61
- Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 2000;24(Suppl 1):S78-84
- Kocak M, Yagli S, Vahapoglu G, Eksioglu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 2002;205:265-70
- Clyti E, Sayavong K, Chanthavisouk K. Dermodecidosis in a patient infected by HIV: successful treatment with ivermectin. Ann Dermatol Venereol 2005;132:459-61
- Draelos ZC, Graupe K. A new topical formulation for the treatment of moderate, papulopustular rosacea: azelaic acid 15% gel [abstract no. P49 plus poster]. 61st Annual Meeting of the American Academy of Dermatology; 21 – 26 Mar 2003; San Francisco, USA
- Kakita LS. Azelaic acid in the treatment of acne, rosacea, and hyperpigmentary skin diseases. Today's Ther Trends 1997;14:251-66
- Akamatsu H, Komuru J, Asad Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 1991;283:162-6
- Jones D. Reactive oxygen species and rosacea. Cutis 2004;74:S17-20
- Berlex Laboratories. Finacea (azelaic acid) gel 15%. Summary of Product Characteristics
- Tauber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans. Exp Dermatol 1992;1:176-9
- Akhavan A. Topical acne drugs: review of clinical properties, systemic exposure and safety. Am J Clin Dermatol 2003;4(7):473-92
- Breathnach AS. Azelaic acid: biological activities and therapeutic applications. Drugs Today 1989;25:463-72
- Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991;41:780-98
- Passi S, Picardo M, Mingrone G, et al. Azelaic acid-biochemistry and metabolism. Acta Derm Venereol Suppl (Stockh) 1989;143:8-13
- Thiboutot D, Thieroff Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003;48:836-45
- Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Result of a randomized trial. Arch Dermatol 2003;139:1444-50
- Wolf JE, Kerrouche N, Arsonnaud S. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis 2006;77(Suppl 4):3-11
- Thiboutot DM, Fleischer AB Jr, Del Rosso JQ, Graupe K. Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol 2008;7:541-6
- Draelos DZ, Graupe K. A new topical formulation for the treatment of mild to moderate papulopustular rosacea: azelaic acid 15% gel. Presented at AAD; 2005
- Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med 2007;9:179-87
- Draelos ZD. Noxious sensory perceptions in patients. Cutis 2004;74:257-60